Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Austrian Post 5.49 € GLS courier 4.99 € DPD courier 4.49 € DPD point 3.49 €

Contact

How to shop

Help

My account

▸ Empty :-(

Biologic and Systemic Agents in Dermatology

Paul Yamauchi

Language

English

Book Hardback

Libristo code: 16830518

Publishers Springer International Publishing AG, January 2018

Written by leading experts in the field and designed for dermatologists and residents, this book inc... Full description

Libristo code: 16830518

438 b

178.99 € VAT included

In stock at our supplier Shipping in 10-13 days

Delivery to Austria

Up to 30 days for returns

Customers also purchased

Gaster Gorm Gallionn

Paperback

16.09 €

Burgen und Schloesser der Harzregion 4 Bernd Sternal

Paperback

14.99 €

Castingprozesse im deutschen Film- und Fernsehbereich Jana Wichmann

Paperback

49.00 €

Le Sujet thique Domingos Vieira

Paperback

47.39 €

Appel ? la fraternité JASON

Paperback

10.79 €

Granice zrównowazonego partnerstwa. Czesc V Boris Zalesski

Paperback

35.29 €

Das Diktat im Orthographieunterricht. Darstellung und Kritik Ann Chef

Paperback

17.95 €

Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agents in the field of dermatology. In the past decade, there have been several groundbreaking advances in medical dermatology. Novel biologic and systemic agents have been developed to treat inflammatory disorders, including psoriasis and atopic dermatitis, as well as skin malignancies such as melanoma. Biologic and Systemic Agents in Dermatology encompasses these developments by describing the mechanism of action of these various agents and the clinical efficacy and safety to treating these respective disorders. The utilization of biologic and systemic agents in other dermatologic conditions, pharmacoeconomics, pharmacovigilance, and clinical trials outcomes are discussed as well as topics including tumor necrosis, conventional systemic agents for psoriatic disease, and oral agents for atopic dermatitis.